A Phase 1-2 Dose-Escalation and Cohort-Expansion Study of Oral Tomivosertib (eFT-508) in Subjects With Hematological Malignancies
Clinical trial NCT02937675 · TERMINATED
Trial details
- NCT number
- NCT02937675
- Sponsor
- Effector Therapeutics
- Status
- TERMINATED
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2017-02-08
- Primary completion
- 2018-11-12
- Enrollment
- 28
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.